A new study published today in JAMA reveals text message reminders for patients who delay refilling their medications didn't help improve how regularly they refilled medications over a year.

Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) seeking approval of TREMFYA® (guselkumab) for ...

The Global Digital Therapeutics (DTx) Market was valued US$ 4.28 billion in 2021 and is predictable to reach US$ 18 billion by 2030; growing at a CAGR of 22.2% from 2021 to 2030. Request To Download ...